Here Comes the Next Wave... of Narratives
New messaging to foster compliance in a new target market.
Pfizer and Moderna are both seeking EUA’s for their spikeshots for little ones.
Right on schedule, here come the stories that claim that we need to get our babies jabbed before the next surge. Omicron variant BA.2 is almost upon us.
“Vaccinating children is really key,” said Dr. David Wohl, a professor of medicine at the University of North Carolina’s division of infectious diseases. “All the ingredients are there to see an uptick starting in very young people, and so that’s what we have to pay attention to.”
https://www.yahoo.com/now/babies-young-kids-covid-19-143741686.html
It’s not surprising. A Civis Analytics messaging study for the COVID vaccine concluded that “protecting children” was the most effective persuasive message to encourage the unvaccinated to get the shot, followed by “financial costs.”
In fairness, they don’t have much choice but to convince us the shots are necessary since they’ve already purchased them. From the above article:
The Biden administration already has secured enough vaccines for children under 6, White House COVID-19 Response Coordinator Jeff Zients said during Wednesday’s briefing.
“We will be ready operationally … when the vaccine is authorized and recommended,” he said. “We’ll have those vaccinations available in tens of thousands of locations across the country that people know and trust.”
But how dangerous is BA.2? And what do these shots, designed for a variant that no longer exists, promise?
“BA.2 doesn't appear to cause more severe illness or evade immunity but may be up to 60% more transmissible than the original omicron variant, said Amber D’Souza, professor at the Johns Hopkins Bloomberg School of Public Health.”
“Although both of the vaccine makers' studies were conducted during the initial omicron wave, there’s no reason to think their vaccines won't be effective against BA.2, said Stephen Kissler, research fellow in the Department of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health.
First off, “There’s no reason to think their vaccines won’t be effective against BA.2” is about as unscientific as it gets.
Secondly… Really???
I can think of a couple of reasons. What about the fact that the spikeshots demonstrated disappointing efficacy against Omicron in children?
“The New York State Department of Health found that the effectiveness of Pfizer’s vaccine against Covid infection plummeted from 68% to 12% for kids in that age group during the omicron surge from Dec. 13 through Jan 24. Protection against hospitalization dropped from 100% to 48% during the same period.”
https://www.cnbc.com/2022/02/28/pfizer-covid-vaccine-was-just-12percent-effective-against-omicron-in-kids-5-to-11-study-finds.html
Furthermore…
“The team of public health officials who conducted the study said the dramatic drop in vaccine effectiveness among children 5 to 11 years old was likely due to the lower dosage they received. Kids in this age group are given two 10-microgram shots, while children aged 12 to 17 receive 30-microgram shots.”
So what dose that mean for kids under five who will get 1/3 of THAT lower dosage? Pfizer’s initial clinical trials have already demonstrated that the first 2 shots were insufficient. And Moderna’s shot doesn’t look any more promising:
In Moderna’s study of 6,700 kids, researchers found the vaccine was 43.7% effective in children 6 months to 2 years, and 37.5% in kids 2 to 6 years. It's a far cry from the 95% efficacy rate first reported in adults against the original coronavirus, but health experts say it's better than nothing – for now.
Better than nothing - for now. That’s what they’re offering our children.
And I beg to differ. It’s not better than nothing.
There have already been 91 child deaths and 1,238 cases of myocarditis in children reported to VAERS following COVID-19 shots.
Healthy kids do not need these shots and parents know this. Over 42,000 of them took the time to voice their concerns ahead of the FDA VRBPAC (Vaccines and Related Biological Products Advisory Committee) meeting, originally scheduled for February 15, to consider the Emergency Authorization approval of Pfizer’s jab for kids under 5. #ParentsAreWatching and they know what’s up. You can read their comments here.
After a significant public outcry, the Pfizer withdrew it’s EUA request and the meeting was postponed. But we knew they’d be back. Expect some new messaging and some new statistical gymnastics in the coming weeks as BigPharma gears up to reframe failure as success.
As for the spike shot however, it will essentially be the same formula that was created for a variant that is now obsolete. Because science.